New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

Cureus, Exploring the Potential of Broadly Neutralizing Antibodies for Treating SARS-CoV-2 Variants of Global Concern in 2023: A Comprehensive Clinical Review

Immune Network

Browse Articles Cellular & Molecular Immunology

Coronavirus spike protein - Wikipedia

Gregory C. Ippolito on LinkedIn: Human Antibodies Target Many Parts of Coronavirus Spike Protein

Lipid-Based Poly(I:C) Adjuvants Strongly Enhance the Immunogenicity of SARS-CoV-2 Receptor-Binding Domain Vaccine

News & Comment Cellular & Molecular Immunology

PDF) New strategy for COVID-19 vaccination: targeting the receptor-binding domain of the SARS-CoV-2 spike protein

Targeting ACE2 as a treatment for COVID

Identification of vaccine targets & design of vaccine against SARS-CoV-2 coronavirus using computational and deep learning-based approaches [PeerJ]